Analysis of the C Upsilon P2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population

Objective: To analyze the CYP2D6 allele frequencies in a Japanese populatio n and to evaluate the effects of CYP2D6 variants on in vivo CYP2D6 activity as measured by the dextromethorphan metabolic ratio (MR). Methods: Ninety-eight unrelated, healthy Japanese men were phenotyped with dextromethorphan and genotyped by the polymerase chain reaction amplificati on method for 7 CYP2D6 alleles. Results:The CYP2D6*1, CYP2D6*10 CYP2D6*2 CYP2D6*5, CYP2D6*4, and CYP2D6*21 allele frequencies in our Japanese subjects were 0.423, 0.408, 0.092, 0.061 , 0.020, and 0.010, respectively. Thirty-three subjects (33.7%) were hetero zygous for *10/*1, and 18 (18.4%) and 17 (17.3%) subjects were homozygous f or *1 and *10 respectively. Subjects who were homozygous for *10 showed the highest dextromethorphan MR among these 3 genotypes. Eighteen subjects (18 .3%) were heterozygous for *2 but their dextromethorphan MR values were not greater than the MR values of subjects who were homozygous for *1. One sub ject was a poor metabolizer phenotypically, and he was homozygous for *5. Conclusions The CYP2D6 allele frequencies in our Japanese subjects differed from those determined in previous studies of white subjects or mainland Ch inese subjects. Individuals homozygous for *10 who have relatively low in v ivo CYP2D6 activity represent almost 20% of the Japanese population. In add ition, we did not identify any subjects with amplified *2 among our 98 Japa nese men.